March 19, 2012
Breaking The Backbone Of Triple-Negative Breast Cancers
Putting the brakes on an abundant growth-promoting protein causes breast tumors to regress, according to a study published on March 19th in the Journal of Experimental Medicine.
Triple-negative breast tumors lack all of the known growth receptors that serve as treatment targets in other types of breast cancer, making this the most clinically challenging subtype of the disease. Patients with these tumors tend to relapse earlier and have shorter disease-free survival.
Together, these results identify a potential new target for triple-negative tumor treatment.
On the Net: